Michael E. Garst
212Patents
24h-index
105Co-inventors
93Inventor score
Filing activity: Sep 10, 1986 → Mar 31, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5688819A | Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents | Chemistry; Metallurgy | 217 | Expired |
| US6403649B1 | Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents | Chemistry; Metallurgy | 176 | Expired |
| US5352708A | Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents | Chemistry; Metallurgy | 112 | Expired |
| US6254860A | Ocular treatment using cyclosporin-A derivatives | Human Necessities | 93 | Expired |
| US6350442B2 | Ocular treatment using cyclosporin-A derivatives | Human Necessities | 88 | Expired |
| US5607978A | Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents | Chemistry; Metallurgy | 75 | Expired |
| US7091232B2 | 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds | Chemistry; Metallurgy | 72 | Expired |
| US6294563A | Combinations of prostaglandins and brimonidine or derivatives thereof | Human Necessities | 68 | Expired |
| US6271220A | Anti-angiogenic agents | Chemistry; Metallurgy | 66 | Expired |
| US5453434A | N-substituted derivatives of 3R,4R-ethyl-[(1-methyl-1H-imidazol-5-yl)methyl]-2-pyrrolidone | Chemistry; Metallurgy | 60 | Expired |
| US5721215A | Injectable therapy for control of muscle spasms and pain related to muscle spasms | Physics | 51 | Expired |
| US6329369A | Methods of treating pain and other conditions | Chemistry; Metallurgy | 47 | Expired |
| US6534542B2 | (2-hydroxy)ethyl-thioureas useful as modulators of &agr;2B adrenergic receptors | Chemistry; Metallurgy | 43 | Expired |
| US6545182B2 | Methods and compositions for modulating alpha adrenergic receptor activity | Chemistry; Metallurgy | 42 | Expired |
| US6203794A | Modification of clostridial toxins for use as transport proteins | Emerging Cross-Sectional Technologies | 38 | Expired |
| US6841684B2 | Imidiazoles having reduced side effects | Chemistry; Metallurgy | 37 | Expired |
| US5756503A | Methods for using (2-imidazolin-2-ylamino) Quinoxaline derivatives | Human Necessities | 35 | Expired |
| US5561132A | Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives | Human Necessities | 31 | Expired |
| US6323204A | Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives | Human Necessities | 31 | Expired |
| US6747025B1 | Kinase inhibitors for the treatment of disease | Chemistry; Metallurgy | 30 | Expired |
| US5703077A | Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives | Human Necessities | 29 | Expired |
| US6093734A | Prodrugs of proton pump inhibitors | Chemistry; Metallurgy | 27 | Expired |
| US6559167B1 | Prodrugs of proton pump inhibitors | Chemistry; Metallurgy | 26 | Expired |
| US7335803B2 | Methods and compositions for modulating alpha adrenergic receptor activity | Human Necessities | 25 | Expired |
| US6452032B1 | Organosilyl compounds having nuclear hormone receptor modulating activity | Chemistry; Metallurgy | 23 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.